Document is current
Any future updates will be listed below
-
Authors
Chen, Yi
To, Minh-Son
Carpenter, Harry J.
Psaltis, Peter J.
Li, Jiawen
-
Funding
Funding for this research was provided by:
Adelaide University
- License Information
-
More Information
Article History
Received: 7 July 2025
Accepted: 28 May 2026
First Online: 11 June 2026
Declarations
:
: M-S.T. is a co-founder of Addend AI Pty Ltd, a medical imaging analysis company. P.J.P. has received research support from Abbott Vascular, Amgen and Biotronik, consulting fees from Amgen, Esperion, Eli Lilly, Novartis, Novo Nordisk and Sanofi, and speaker honoraria from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Merck Schering-Plough, Pfizer, Novartis, Novo Nordisk and Sanofi. He also serves as an unpaid board director of Corcillum Pty Ltd. H.J.C holds a management position and equity in Corcillum Pty Ltd. J. L. is the founder and Director of Theia Medical Pty Ltd, a company that develops medical imaging devices. Addend AI Pty Ltd, Corcillum Pty Ltd and Theia Medical Pty Ltd did not contribute to or participate in this study.
